TRIMODAL PREHABILITATION IN GASTROINTESTINAL CANCER

NCT ID: NCT07281248

Last Updated: 2025-12-15

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 30 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-08-28
• Study Completion Date: 2027-09-01

Brief Summary

Digestive cancers account for a substantial proportion of oncological patients, representing over 20% of cases treated in hospitals, and are generally managed through a multidisciplinary approach that has markedly improved survival outcomes over recent decades. Surgical resection remains the cornerstone of curative treatment, often preceded by neoadjuvant chemotherapy, radiotherapy, or combined modalities. Notably, a significant proportion of patients eligible for abdominal surgery are older adults, with approximately one in three being over 75 years of age. Advances such as Enhanced Recovery After Surgery (ERAS) protocols and the centralization of complex surgical procedures have contributed to better outcomes, including higher rates of radical resections, improved survival, reduced postoperative complications, and shorter hospital stays.

While some risk factors are non-modifiable, such as age, sex, tumor stage, comorbidities, and tumor biology, several modifiable factors can be optimized prior to surgery to improve postoperative outcomes. These include smoking cessation, enhancement of aerobic capacity and muscular strength, nutritional optimization, emotional resilience, and correction of anemia or other metabolic derangements. Preoperative exercise, ideally embedded within a multimodal prehabilitation program, is recommended for all patients undergoing major surgery. The neoadjuvant period represents a valuable window to implement trimodal prehabilitation strategies encompassing physical exercise, nutritional support, and psychological interventions, aimed at reducing postoperative complications, shortening hospital length of stay, and improving functional recovery.

Physical fitness in this context is multidimensional, encompassing aerobic capacity, muscle strength, and body composition. Aerobic capacity predicts postoperative complications and length of hospital stay, while low muscle strength and sarcopenia are associated with higher morbidity and poorer prognosis. Inspiratory muscle training can further reduce pulmonary complications and accelerate recovery. Nutritional status is a critical determinant of surgical outcomes in gastrointestinal cancer, with malnutrition affecting up to 80% of patients at diagnosis. Comprehensive assessment, including dietary intake, anthropometric measurements, physical examination, and biomarkers such as albumin and transferrin, is essential, and targeted interventions including protein supplementation, pancreatic enzyme replacement, or tailored dietary strategies should be implemented when indicated. Body composition, particularly sarcopenia and cachexia, is closely linked to both nutrition and exercise, and can be assessed through imaging techniques such as DXA, CT, or MRI, or via bioelectrical impedance in research settings, with simpler bedside assessments used in clinical practice.

Emotional wellbeing also plays a significant role, as preoperative anxiety and depression can negatively influence recovery, adherence to rehabilitation, and overall quality of life. Psychological support, stress management, and behavioral interventions can improve patient engagement and enhance outcomes. The physiological principles of hormesis and cross-stressor adaptation suggest that controlled exercise can improve resilience to both physical and psychological stressors, including the stress of surgery itself. Additional modifiable factors such as absolute cessation of alcohol and tobacco, glycemic control in diabetic patients, correction of anemia (including iron deficiency), and frailty assessment in older adults are critical components of preoperative optimization.

Major abdominal surgery carries substantial risk, including infections, bleeding, and anastomotic complications, which directly impact quality of life and lengthen hospitalization. Evidence from randomized controlled trials indicates that multimodal prehabilitation effectively reduces postoperative complications and shortens hospital stay. However, motivating patients to engage in exercise during neoadjuvant therapy can be challenging due to treatment-related fatigue, nausea, and other side effects. Integrating behavioral theories such as Self-Determination Theory and the Theory of Planned Behavior can enhance intrinsic motivation by fostering autonomy, competence, and relatedness, and addressing attitudes, subjective norms, and perceived behavioral control, ultimately promoting adherence to prehabilitation programs and optimizing postoperative recovery.

Detailed Description

9. INTERVENTION PHYSICAL PREHABILITATION PROGRAMME Prior to the intervention, a complete physical assessment will be carried out. In addition, a motivational interview will be conducted, which is a promising technique for addressing many types of behavioural changes in cancer patients or survivors.

The training will consist of two main components (cardiorespiratory endurance and muscle strength) and two secondary components (flexibility and balance). A plan will be followed to increase the intensity of the training in relation to the patients' tolerance and functional capacity.

AEROBIC EXERCISE: A frequency of at least 5 days per week should be achieved in the case of moderate exercise and at least 2 days in the case of vigorous exercise, aiming for a total of 150-300 minutes of moderate-vigorous physical activity or 75-150 minutes in the case of vigorous activity (WHO, 2020). Moderate intensity is considered to be training at 40-59% of peak oxygen consumption reserve (the difference between consumption at maximum exercise and at rest), or training at 55-69% of maximum HR or 6-7 on the Borg scale. Vigorous intensity is considered to be training at 60-84% of peak oxygen consumption, or training at 70-89% of maximum HR or 8-9 on the Borg scale.

The type of aerobic exercise will differ depending on the stage of the patient's treatment and their tolerance. When exercising independently, they can do most of the exercise by walking and cycling (which trains the large muscle groups). If their physical condition allows it, they could do interval training. If the patient tolerates it, the intensity can be increased, but it must be remembered that as they progress in training, they also progress in chemotherapy treatment and their tolerance to exercise decreases.

In the supervised part, the training methodology will be varied (i.e. circuits with different activities, games, etc.) in order to avoid monotony and boredom, which have been linked to lower motivation to engage in physical activity. In any case, training will be planned and periodised on a day-to-day basis in order to adapt the training sessions to the individual needs of each patient.

STRENGTH TRAINING: Two supervised sessions per week should be carried out, which will include an individualised progression from single-joint exercises to multi-joint exercises. Initially, priority will be given to the volume and subsequently to the intensity of the training. There will be a daily schedule based on the patient's daily capacity due to the effect of the treatment and their physical condition. Therefore, different adaptations will be designed, and the patient will be able to choose the training that best suits that day, all of which will meet the training objectives included in the prehabilitation programme. With a Borg scale rating of 7-8. Flexibility and balance exercises will be recommended.

INSPIRATORY MUSCLE TRAINING: 5 weekly sessions of 15 minutes, with an initial load of 20-30% of maximum inspiratory pressure until reaching 60%. The first sessions will always be supervised. Expiratory muscles-vagus nerve: Patients will be taught to breathe at a slow pace for 5 minutes. Breathing will be performed using biased patterns: Inhale and count 1-5. Hold your breath and count 1-2. Exhale and count 1-7.

In our first programme, we were able to demonstrate that supervised exercise during very demanding chemotherapy treatment such as FOLFIRINOX was feasible and achieved very high adherence and a very good recruitment rate. For this reason, in this programme we have increased the adherence requirements to consider it feasible. 100% adherence will be adherence to all sessions.

The face-to-face training sessions will take place on Tuesdays and Thursdays at the 'Terra' cross-fit space in Majadahonda.

NUTRITIONAL PREHABILITATION PROGRAMME The nutrition specialist must understand each subject's diet and identify any nutritional deficiencies that may be occurring. They must help the patient to optimise their nutrition. It is critical to identify malnourished patients, in which case nutritional supplements will be provided by the responsible physicians. Nutritional support will be in line with international recommendations. Follow-up by a nutrition specialist will be guaranteed with monthly sessions, which may be increased if a high risk of nutritional compromise is identified.

The consumption of protein after strength training sessions should be promoted within the prehabilitation programme.

PSYCHOLOGICAL PREHABILITATION PROGRAMME The psychologist will identify those patients who require psychological intervention. The aim of the psychologist's intervention is twofold. On the one hand, they will try to achieve high adherence to the prehabilitation programme and, on the other, they will prepare the patient to face complex surgery. Psychological support will be guaranteed during prehabilitation in monthly sessions, which may be conducted individually or in groups.

EXTRACTION OF BIOLOGICAL SAMPLES Blood samples will be taken at baseline and before surgery to study aspects related to the programme in the future, depending on findings and future funding.

In addition, the possibility of taking blood samples before and after the first training session will be explored

Conditions

Digestive Neoplasms

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: NONE

Study Groups

Training group

Gastrointestinal cancer patients will participate in a trimodal prehabilitation program, including nutrition, psychological support, and exercise interventions.

Group Type: EXPERIMENTAL

TRIMODAL PREHABILITATION

Intervention Type: COMBINATION_PRODUCT

Gastrointestinal cancer patients (not stage 4) will undergo trimodal prehabilitation: nutrition, psychological, and exercise support.

Interventions

TRIMODAL PREHABILITATION

Gastrointestinal cancer patients (not stage 4) will undergo trimodal prehabilitation: nutrition, psychological, and exercise support.

Intervention Type: COMBINATION_PRODUCT

Eligibility Criteria

Inclusion Criteria

• More than 18 years old
• ECOG 0-2
• Being able to complete the mile-time test
• Stages I-III
• Being able to understand the informed consent
• Gastrointestinal cancer diagnosed

Exclusion Criteria

• Metastatic cancer

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Puerta de Hierro University Hospital

OTHER

Sponsor Role: lead

Responsible Party

Ana Ruiz-Casado

PRINCIPAL INVESTIGATOR

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Ana Ruiz Casado Principal Investigator, PhD, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitario Puerta de Hierro

Locations

Hospital Universitario Puerta de Hierro Majadahonda

Madrid, Madrid, Spain

Site Status: RECRUITING

Countries

Spain

Central Contacts

Ana Ruiz Casado MD, PhD, Medical oncologist

Role: CONTACT

arcasado@salud.madrid.org

607890187 ext. +34

María Romero Elías MsC, PhD

Role: CONTACT

mromero@idiphim.org

634439023 ext. +34

Facility Contacts

ANA RUIZ CASADO, MD

Role: primary

arcasado@salud.madrid.org

607890187 ext. +34

Other Identifiers

SEOM

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

PREH-PHM-03

Identifier Type: -

Identifier Source: org_study_id